Performance of a vancomycin dosage regimen developed for obese patients
American Journal of Health-System Pharmacy, 06/08/2012
Reynolds DC et al. – Compared with the original vancomycin protocol for obese patients, a revised vancomycin protocol using lower total daily doses improved the attainment of target trough concentrations, with minimal nephrotoxicity.



